Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retinal Degenerations”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04224207
What this trial is testing

Management of Retinitis Pigmentosa by Mesenchymal Stem Cells by Wharton's Jelly Derived Mesenchymal Stem Cells

Who this might be right for
Retinitis PigmentosaInherited Retinal Dystrophy
Ankara Universitesi Teknokent 32
Post-approval studies (Phase 4)Ended earlyNCT02002377
What this trial is testing

Intravitreal Aflibercept in Wet Age Related Macular Degeneration Patients With an Incomplete Response to Routine Ranibizumab Injections

Who this might be right for
Age Related Macular Degeneration
Unity Health Toronto 23
Not applicableLooking for participantsNCT06619405
What this trial is testing

AMD and Validation Rod-Meditated Dark Adaptation With Everyday Task Performance

Who this might be right for
Age-Related Macular Degeneration
Duke University 100
Post-approval studies (Phase 4)UnknownNCT02802657
What this trial is testing

Efficacy and Safety of "Treat-and-Extend" Regimen Versus "Pro Re Nata" of Conbercept in Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Xiaodong Sun 141
Testing effectiveness (Phase 2)Study completedNCT02186119
What this trial is testing

Abicipar Pegol in Patients With Diabetic Macular Edema

Who this might be right for
Macular Edema
Allergan 151
Not applicableEnded earlyNCT03894020
What this trial is testing

GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)

Who this might be right for
Dry Age-related Macular DegenerationMacular DegenerationRetinal Disease+3 more
Gyroscope Therapeutics Limited 83
Not applicableUnknownNCT05547789
What this trial is testing

Assessment Of Diabetic Maculopathy Changes After Phacoemulsification by Using Optical Coherence Tomography

Who this might be right for
Maculopathy
Assiut University 30
Not applicableEnded earlyNCT04276610
What this trial is testing

Words on the Brain: Can Reading Rehabilitation for Age-Related Vision Impairment Improve Cognitive Functioning?

Who this might be right for
Age-related Macular DegenerationDementiaLow Vision+4 more
Université de Montréal 38
Testing effectiveness (Phase 2)Study completedNCT05637255
What this trial is testing

A Randomized, Double Masked, Parallel Group, Dose-finding Study to Evaluate SYL1801 in Patients With Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Wet Macular DegenerationNeovascular Age-related Macular DegenerationMacular Degeneration
Sylentis, S.A. 99
Not applicableEnded earlyNCT02994368
What this trial is testing

"Natural History" Study of Choroideremia

Who this might be right for
Choroideremia
4D Molecular Therapeutics 57
Not applicableStudy completedNCT04637217
What this trial is testing

Retinal Neurodegenerative and Vascular Changes in Diabetic Patients

Who this might be right for
Diabetic RetinopathyNeurodegeneration
Iuliu Hatieganu University of Medicine and Pharmacy 97
Not applicableStudy completedNCT05447650
What this trial is testing

Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration (i-SIGHT)

Who this might be right for
Age-Related Macular DegenerationDry Age-related Macular DegenerationNonexudative Age-related Macular Degeneration
i-Lumen Scientific, Inc. 95
Not applicableStudy completedNCT06860568
What this trial is testing

The GA in HSI Study

Who this might be right for
Geographic AtrophyHealthy
Optina Diagnostics Inc. 42
Testing effectiveness (Phase 2)Looking for participantsNCT05626920
What this trial is testing

Disulfiram for Treatment of Retinal Degeneration

Who this might be right for
Inherited Retinal Dystrophy Primarily Involving Sensory Retina
University of Washington 30
Not applicableNot Yet RecruitingNCT06908161
What this trial is testing

Functional Assessments in Vision Impairment

Who this might be right for
Retinitis Pigmentosa (RP)Diabetic Retinopathy (DR)Age Related Macular Degeneration (AMD)+2 more
Center for Eye Research Australia 45
Testing effectiveness (Phase 2)Looking for participantsNCT06242379
What this trial is testing

Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
Mahidol University 15
Testing effectiveness (Phase 2)Study completedNCT00492284
What this trial is testing

Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)

Who this might be right for
Choroidal NeovascularizationMacular Degeneration
QLT Inc. 162
Post-approval studies (Phase 4)Study completedNCT00682240
What this trial is testing

Morphological and Functional Retinal Changes Following Retinal Photocoagulation

Who this might be right for
Proliferative Diabetic RetinopathyMacular Edema
Medical University of Vienna 64
Not applicableUnknownNCT04419285
What this trial is testing

Mobility Protocol Adapted for Advanced Visually Impaired Subjects

Who this might be right for
Pigmentary Retinopathy
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 50
Early research (Phase 1)Looking for participantsNCT06291935
What this trial is testing

Safety and Tolerability of Intravitreal Administration of VG901 in Patients With Retinitis Pigmentosa Due to Mutations in the CNGA1 Gene

Who this might be right for
Retinitis Pigmentosa
VeonGen Therapeutics GmbH 6
Next Page